Seeger Weiss, Chris Seeger Named Elite Trial Lawyers Plaintiff Firm of the Year and Plaintiff Attorney of the Year Finalists; Parvin Aminolroaya Wins Elite Women of the Plaintiffs Bar Award

Seeger Weiss is pleased to announce that the firm and several of its partners have won or are finalists for multiple 2024 National Law Journal Elite Trial Lawyers Awards. Seeger Weiss was named a finalist for: Plaintiffs Firm of the Year Environmental Protection Practice Group of the Year Government Representation Practice Group of the Year […]

May 13, 2024

Seeger Weiss is pleased to announce that the firm and several of its partners have won or are finalists for multiple 2024 National Law Journal Elite Trial Lawyers Awards.

Seeger Weiss was named a finalist for:

  • Plaintiffs Firm of the Year
  • Environmental Protection Practice Group of the Year
  • Government Representation Practice Group of the Year
  • Mass Torts Practice Group of the Year
  • Pharmaceutical Litigation Practice Group of the Year
  • Products Liability categories Practice Group of the Year

Founding partner Chris Seeger is a finalist for Plaintiff Attorney of the Year. In 2023, Seeger had an unprecedented run of success, finalizing major settlements on behalf of injured plaintiffs in complex cases. In his role as co-lead counsel, Seeger negotiated a more than $6 billion settlement to resolve the 3M Combat Arms Earplug Litigation. He also reached settlements worth more than $533.5 million in the Proton Pump Inhibitor Litigation and an uncapped $600 million agreement to settle economic loss claims in the Philips Recalled CPAP, Bi-Level Pap, and Mechanical Ventilator Products Litigation.

Partner Parvin Aminolroaya, who was recently appointed co-lead counsel in the Glucagon-like Peptide-1 Receptor Agonists Litigation, was selected as an Elite Women of the Plaintiffs Bar Award winner. Parvin joined Seeger Weiss in 2008 and has proved her value as a skilled litigator, helping lead some of the most significant and complex mass tort and class action cases.  Notably, she served as co-lead counsel in the Elmiron (Pentosan Polysulfate Sodium) Litigation which brought compensation and justice to women for their injuries using the product. This award is a testament to the incredible work Parvin has done throughout her career at Seeger Weiss.

The National Law Journal was founded in 1978 to report on legal information of national importance to attorneys and cover legal news for the business and private sectors. Their prestigious Elite Trial Lawyers awards spotlight industry-leading plaintiff lawyers and firms. Every year editors and reporters review submissions to select finalists for an honoree’s list and each year’s winner. No aspect of this or any advertisement has been approved by the Supreme Court of New Jersey or a court or authority of any jurisdiction. The selection methodology for all Elite Trial Lawyers awards can be found here.

Prior results do not guarantee or predict a similar outcome in any future matter.

Related News

March 12, 2026
Seeger Weiss Partner Parvin Aminolroaya and Counsel Max Kelly Appointed to Leadership Roles in GLP-1 NAION Products Liability Litigation

Seeger Weiss is proud to announce that Partner Parvin Aminolroaya has been appointed Co-Lead Counsel for Plaintiffs in the In Re: GLP-1 RAS Non-arteritic Anterior Ischemic Optic Neuropathy Products Liability Litigation and Counsel Max Kelly has been appointed to the Plaintiffs’ Executive Committee. The litigation involves claims that GLP-1 receptor agonist drugs including Ozempic, Wegovy, […]

Read More
February 18, 2026
Twelve Seeger Weiss Attorneys Named to The 2026 Lawdragon 500 Leading Plaintiff Consumer Lawyers Guide

Seeger Weiss is proud to announce that twelve Seeger Weiss attorneys have been selected for inclusion in the 2026 Lawdragon 500 Leading Plaintiff Consumer Lawyers guide. Congratulations to Christopher Seeger, Stephen Weiss, Parvin K. Aminolroaya, Ben Barnett, David R. Buchanan, Steven Daroci, Scott Alan George, Shauna Itri, Diogenes P. Kekatos, Michael L. Rosenberg, Jennifer Scullion, […]

Read More
February 17, 2026
$7.25 Billion Nationwide Roundup / Glyphosate Class Action Settlement To Provide Compensation To Those Diagnosed With Non-Hodgkin Lymphoma After Exposure To Weedkiller

ST. LOUIS, MO – A proposed nationwide class-action settlement resolving claims that exposure to Roundup herbicides caused non-Hodgkin lymphoma (NHL) was filed today in the 22nd Judicial Circuit Court for the City of St. Louis, Missouri. The settlement would make up to $7.25 billion available to compensate individuals across the United States who were exposed […]

Read More